GD
Gill David N
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Gill David N, Director. Officer active across 4 companies, notably Strongbridge Biopharma plc. In total, 15 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €110k. History available since 14 May 2021. The latest transaction was disclosed on 17 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Gill David N
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
45,559 shares0Common StockSEC:0001570562-26-000020:0
5,825 shares@ US$8.60100.0% of flowCommon StockSEC:0001106519-25-000005:0
25,080 shares0Common StockSEC:0001415889-25-019046:0
7,364 shares0Common StockSEC:0001570562-25-000039:0
3,495 shares0Common StockSEC:0001104659-24-071399:0
3,643 shares@ US$12.724739.0% of flowCommon StockSEC:0001570562-24-000090:0
6,464 shares0Common StockSEC:0001570562-24-000024:0
2,330 shares0Common StockSEC:0001104659-23-070043:0
8,293 shares0Common StockSEC:0001570562-23-000021:0
5,313 shares@ US$13.0970.016% mcap100.0% of flowCommon StockSEC:0001570562-22-000104:0
15,568 shares0Common StockSEC:0001570562-22-000049:0
78,058 sharesOrdinary SharesSEC:0001179110-21-009277:0
17,763 shares@ US$2.0646.0% of flowOrdinary SharesSEC:0001179110-21-009218:0
40,000 shares0Ordinary SharesSEC:0001179110-21-005555:0
19,075 shares@ US$2.3554.0% of flowOrdinary SharesSEC:0001179110-21-005441:0
About Gill David N
GILL DAVID N is Administrateur at Evolus, Inc., Y-mAbs Therapeutics, Inc. and Strongbridge Biopharma plc. He has 15 filings in total, and in the 15 most recent filings we hold, the transactions run from 2021-05-17 to 2026-02-19, with EUR 0 of buys and EUR 152186 of sells, and the most frequent transaction nature being Attribution.